Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sims K Kochi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Review of Vaccines|August 7, 2003
Advances in the development of bacterial vector technologySims K Kochi, Kevin P Killeen, Una S Ryan
Current Opinion in Molecular Therapeutics|March 1, 2005
Recent advances in the development of live, attenuated bacterial vectorsKenneth L Roland, Steven A Tinge, Kevin P Killeen, et al.
Vaccine|March 27, 2010
Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidatesKenneth L Roland, Steven A Tinge, Sims K Kochi, et al.
Vaccine|November 30, 2007
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coliKenneth L Roland, Cheryl Cloninger, Sims K Kochi, et al.
Infection and Immunity|March 16, 2002
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccineMitchell B Cohen, Ralph A Giannella, Judy Bean, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|August 7, 2003
Advances in the development of bacterial vector technologySims K Kochi, Kevin P Killeen, Una S Ryan
Current Opinion in Molecular Therapeutics|March 1, 2005
Recent advances in the development of live, attenuated bacterial vectorsKenneth L Roland, Steven A Tinge, Kevin P Killeen, et al.
Vaccine|March 27, 2010
Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidatesKenneth L Roland, Steven A Tinge, Sims K Kochi, et al.
Vaccine|November 30, 2007
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coliKenneth L Roland, Cheryl Cloninger, Sims K Kochi, et al.
Infection and Immunity|March 16, 2002
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccineMitchell B Cohen, Ralph A Giannella, Judy Bean, et al.
Pageof 1